Tenax Therapeutics, Inc.
TENX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000034956
In the last 90 days, Tenax Therapeutics, Inc. insiders filed 6 open-market purchases and 0 sales; 111 institutions reported holding it in 13F filings for Q2 2026, worth $441.4M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Tenax Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +3 vs. Q1 2025
- Shares held
- 2.23M
- +225.6K (+11.2%) vs. Q1 2025
- Total value
- $12.9M
- −$184.3K (−1.4%) vs. Q1 2025
- New holders
- 3
- 6 more added
- Sold out
- 0
- 4 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TENX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $441.4M |
| Q1 2026 | 81 | $341.0M |
| Q4 2025 | 49 | $85.9M |
| Q3 2025 | 34 | $35.9M |
| Q2 2025 | 26 | $12.9M |
| Q1 2025 | 23 | $13.1M |
| Q4 2024 | 21 | $8.43M |
| Q3 2024 | 19 | $4.25M |
| Q2 2024 | 11 | $57.2K |
| Q1 2024 | 9 | $30.5K |
| Q4 2023 | 17 | $367.6K |
| Q3 2023 | 16 | $184.8K |
| Q2 2023 | 15 | $119.2K |
| Q1 2023 | 13 | $230.6K |
| Q4 2022 | 19 | $691.8K |
| Q3 2022 | 29 | $1.24M |
| Q2 2022 | 25 | $2.08M |
| Q1 2022 | 25 | $6.54M |
| Q4 2021 | 28 | $8.38M |
| Q3 2021 | 25 | $13.6M |
| Q2 2021 | 25 | $7.32M |
| Q1 2021 | 26 | $7.21M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Tenax Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| RTW Investments, LP | 378,346 | $2.18M | 0.03% | 00.0% | Unchanged |
| BVF Inc | 339,549 | $1.98M | 0.07% | 00.0% | Unchanged |
| Millennium Management LLC | 233,714 | $1.36M | 0.00% | +207,088+777.8% | Added |
| Vivo Capital, LLC | 208,333 | $1.20M | 0.12% | 00.0% | Unchanged |
| Morgan Stanley | 178,010 | $1.03M | 0.00% | +56,916+47.0% | Added |
| Janus Henderson Group PLC | 166,666 | $978.3K | 0.00% | 00.0% | Unchanged |
| Integral Health Asset Management, LLC | 167,000 | $961.9K | 0.09% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 155,557 | $896.0K | 0.15% | +86,816+126.3% | Added |
| VR Adviser, LLC | 98,564 | $567.7K | 0.04% | −109,769−52.7% | Reduced |
| Adage Capital Partners GP, L.L.C. | 83,333 | $480.0K | 0.00% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 83,333 | $480.0K | 0.48% | 00.0% | Unchanged |
| Vestal Point Capital, LP | 53,439 | $307.8K | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 34,236 | $199.9K | 0.00% | +895+2.7% | Added |
| Vanguard Group Inc | 22,287 | $130.2K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 15,930 | $93.0K | 0.00% | −3,313−17.2% | Reduced |
| Citadel Advisors LLC | 10,345 | $60.4K | 0.00% | −12,796−55.3% | Reduced |
| Raymond James Financial Inc | 1,503 | $8.66K | 0.00% | +1,503 | New |
| Tower Research Capital LLC (TRC) | 1,249 | $7.19K | 0.00% | +1,057+550.5% | Added |
| BlackRock, Inc. | 300 | $1.73K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 249 | $1.43K | 0.00% | +20+8.7% | Added |
| UBS Group AG | 14 | $81 | 0.00% | −2,879−99.5% | Reduced |
| Barclays PLC | 11 | $63 | 0.00% | +11 | New |
| UMA Financial Services, Inc. | 1 | $6 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 1 | $6 | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 1 | $6 | 0.00% | +1 | New |
| Union Bancaire Privee, UBP SA | 1 | $5 | 0.00% | 00.0% | Unchanged |